Company Filing History:
1 out of 3,376 
1 out of 134 
Years Active: 2022
Title: Innovations of Wei-Sheng Sun in Probiotic Research
Introduction
Wei-Sheng Sun is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of probiotics, particularly in the fight against antibiotic-resistant bacteria. His work focuses on developing innovative solutions to combat vancomycin-resistant enterococci, a serious health concern.
Latest Patents
Wei-Sheng Sun holds a patent titled "Probiotic and probiotic combination for inhibition of vancomycin-resistant enterococci and use thereof." This patent describes a probiotic combination that effectively inhibits the growth, host cell attachment, and virulence of vancomycin-resistant enterococci. The probiotic combination also targets virulence gene expression, including genes such as asa1, acm, ebpA, ebpB, ebpC, efaA, sagA, esp, sgrA, and scm.
Career Highlights
Throughout his career, Wei-Sheng Sun has worked with prominent organizations, including Delta Electronics, Inc. and Taipei Medical University. His experience in these institutions has allowed him to collaborate with other experts in the field and advance his research.
Collaborations
Wei-Sheng Sun has collaborated with notable colleagues such as Shiuh-Bin Fang and Kun-Nan Tsai. These partnerships have contributed to the development of his innovative probiotic solutions.
Conclusion
Wei-Sheng Sun's work in probiotic research highlights the importance of innovation in addressing public health challenges. His contributions to the field are paving the way for new treatments against antibiotic-resistant bacteria.